BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31283609)

  • 1. Isolated Small Bowel Metastasis From Gastric Cancer Detected by 18F-FDG PET/CT.
    Fan Q; Su M
    Clin Nucl Med; 2019 Oct; 44(10):840-841. PubMed ID: 31283609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Bowel Metastasis From Hepatocellular Carcinoma Detected by 18F-FDG PET/CT But Not by 11C-Acetate PET/CT.
    Yoo SW; Kim DY; Lee C; Min JJ; Kwon SY
    Clin Nucl Med; 2017 Dec; 42(12):966-967. PubMed ID: 29076914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging.
    Strobel K; Skalsky J; Hany TF; Dummer R; Steinert HC
    Clin Nucl Med; 2007 Mar; 32(3):213-4. PubMed ID: 17314600
    [No Abstract]   [Full Text] [Related]  

  • 4. Small bowel metastasis from lung cancer detected on FDG PET/CT.
    Tulchinsky M; Coquia S; Wagner H
    Clin Nucl Med; 2009 Jul; 34(7):446-8. PubMed ID: 19542953
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Xie X; Tu N; Wang Q; Cheng Z; Han X; Bu L
    Thorac Cancer; 2020 Aug; 11(8):2325-2330. PubMed ID: 32410331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
    Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
    Prakoso E; Fulham M; Thompson JF; Selby WS
    Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT Imaging of Primary Gastric Lymphoma.
    Davis BS; Thompson TA; Wolin EA
    J Nucl Med Technol; 2016 Dec; 44(4):263-264. PubMed ID: 27493260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
    Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
    Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
    Sharma P; Dwary AD; Khan EM
    Clin Nucl Med; 2017 Oct; 42(10):807-808. PubMed ID: 28806259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 FDG PET-CT imaging of intestinal metastasis from primary lung cancer.
    Kim MS; Cheon GJ; Lim SM; Kim CH; Lee JC
    Clin Nucl Med; 2008 Dec; 33(12):870-1. PubMed ID: 19033792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
    Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
    Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
    Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT in Prostate Metastasis From Gastric Cancer.
    Ji X; Dong A
    Clin Nucl Med; 2022 Oct; 47(10):918-920. PubMed ID: 35605057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
    Wang W; Yuan L; Kan Y; Yang J
    Clin Nucl Med; 2017 Sep; 42(9):725-727. PubMed ID: 28719444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.